Indication
Treatment of tumour-induced hypercalcaemia with or without metastases.
Loading your page…
Loading your page…
Hypercalcemia;Cancer
Marketing Authorisation Holder: Roche Registration Ltd.
EMA Authorisation: 25/06/1996
INN: ibandronic acid
AI Drug & Interaction Analysis
Free account required
Ask Osler about Destara: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.